Cypress Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.22M Sell
47,963
-104
-0.2% -$4.81K 0.64% 35
2025
Q1
$2.93M Buy
48,067
+479
+1% +$29.2K 0.85% 20
2024
Q4
$2.69M Buy
47,588
+9,693
+26% +$548K 0.77% 22
2024
Q3
$1.96M Buy
37,895
+3,014
+9% +$156K 0.51% 41
2024
Q2
$1.45M Buy
34,881
+1,234
+4% +$51.2K 0.36% 43
2024
Q1
$1.82M Buy
33,647
+30
+0.1% +$1.63K 0.5% 39
2023
Q4
$1.72M Buy
33,617
+1,124
+3% +$57.7K 0.49% 41
2023
Q3
$1.89M Sell
32,493
-598
-2% -$34.7K 0.55% 38
2023
Q2
$2.12M Buy
33,091
+837
+3% +$53.5K 0.61% 34
2023
Q1
$2.24M Buy
32,254
+858
+3% +$59.5K 0.7% 25
2022
Q4
$2.26M Buy
31,396
+281
+0.9% +$20.2K 0.71% 29
2022
Q3
$2.21M Buy
31,115
+2,273
+8% +$162K 0.78% 19
2022
Q2
$2.22M Buy
28,842
+1,356
+5% +$104K 0.32% 51
2022
Q1
$2.01M Buy
27,486
+984
+4% +$71.9K 0.25% 67
2021
Q4
$1.65M Buy
26,502
+852
+3% +$53.1K 0.19% 89
2021
Q3
$1.52M Buy
25,650
+2,264
+10% +$134K 0.19% 92
2021
Q2
$1.56M Buy
23,386
+3,286
+16% +$220K 1.53% 24
2021
Q1
$1.27M Buy
20,100
+1,570
+8% +$99.1K 0.52% 43
2020
Q4
$1.15M Sell
18,530
-204
-1% -$12.7K 0.52% 39
2020
Q3
$1.14M Sell
18,734
-211
-1% -$12.9K 0.53% 35
2020
Q2
$1.11M Buy
+18,945
New +$1.11M 0.49% 34
2019
Q4
$1.01M Buy
15,762
+1,046
+7% +$67.2K 0.43% 30
2019
Q3
$746K Buy
14,716
+1,274
+9% +$64.6K 0.34% 50
2019
Q2
$609K Buy
13,442
+827
+7% +$37.5K 0.28% 56
2019
Q1
$602K Buy
12,615
+1,279
+11% +$61K 0.25% 58
2018
Q4
$589K Buy
+11,336
New +$589K 0.27% 43